KRAS Mutation Subtypes Show Distinct Immune Responses, Guiding Personalized Cancer Treatment
New research reveals that different KRAS mutation types create distinct tumor ecosystems with varying immune responses, potentially enabling personalized treatment strategies combining mutation-specific inhibitors with immunotherapy.